Call Us Today:
949.200.1600

Basal Cell Carcinoma

Home > Diagnosis > Basal Cell Carcinoma

About Basal Cell Carcinoma

Basal cell carcinoma (BCC) is the most common form of skin cancer arising from basal cells residing within the dermal-epidermal junction of the skin. This cancer is usually easily detectable as it forms plaques, nodules, or scabs on the surface of the skin. Basal Cell Carcinomas of the skin are the least aggressive skin cancers that we treat in Orange County. These cancers only cause local tissue invasion and some destruction, and almost never metastasize. Basal Cell Carcinoma of the skin are very slow growing as a rule with some lesions taking many months to evolve.

 

We perform basal cell carcinoma treatment from our Newport Beach clinic. Treatment of these cancers are numerous including curettage, simple excision, Moh’s surgery, and superficial radiotherapy. Other alternative treatments can include topical cancer treatment creams.

Diagnosis

A lesion presenting as a non-healing skin lesion is biopsied. BCC can be diagnosed with a simple shave biopsy of the skin lesion. Punch and incisional biopsies can also be done. Diagnostic non-invasive techniques include Reflectance Confocal Microscopy (RCM). Most commonly used biopsy technique is a shave biopsy. Even very thin shave biopsy that leave no visible scars can diagnose BCC. In some cases incisional or punch biopsies may be necessary to adequately diagnose BCC, but that is uncommon. Incisional or punch biopsy provides much more material for microscopic evaluation if there is any doubt about the diagnosis. However, these techniques require a suture and may leave a visible scar. BCC are easily diagnosed under a microscope due to obvious staining of clusters of cancerous cells. Frequently dermatologists read their own biopsies in their office. Outside labs can also easily diagnose BCC with a 2 day turnaround time. RCM is noninvasive technique that leaves no scar, but requires 10-20 mins of scanning the patient’s lesion. This technique is reserved for special cases.
 
BCC classically presents as a pearly nodule. BCC can be a visually definable lesion. The exact extent of Basal Cell Carcinoma can frequently be determined by an experienced eye and good lighting. Visually defining the extent of the lesion helps with treatment planning. Another hallmark of BCC is its friability - fragility. The surface of BCC can rub off and bleed easily. This would appear as a a recurrent bleeding scab. Some BCC’s can be infiltrative. They present as a plaque within the skin that changes skin texture and appearance.
 
BCC is easily seen with frozen histopathology. Freshly biopsied tissue can be placed on a slide and stained for microscopy using a freezing technique. That is why Basal Cell Carcinoma can be treated with Moh’s Surgery which utilizes frozen section evaluation at the time of surgery.

More Complicated BCC

Rarely Basal Cell Carcinoma can be very aggressive infiltrating deeply into tissue. Some BCC’s can invade from skin into bone and cartilage. Some can even penetrate into vital structures such as ear canals and orbit. Although most BCC are visible to the skin, some can grow rapidly and extensively without showing much surface changes. Some rare BCC can be so deeply invasive and infiltrative that surgical treatment  is no longer possible. We have had experiences with BCC’s invading cranial cavity, orbit, and maxilla. Some of these require radical soft tissue and bone resection or orbital exenteration. Some BCC’s are simply not treatable surgically.

Related Articles

Upper-Chest-BCC-perineural-invasion-Mohs-and-closure-SCARS-center-wide-local-excision-SRT-radiotherapy-orange-county-skin-cancer.JPG
Upper Chest BCC PNI
HISTORY 53-year-old man presents with a 4-year-history of BCC of upper chest.  The tumor measured 12 cm x 6 cm. Wide local excision with 1 cm margins on 11/10/2017 found clear margins and perineural invasion. The nerves up to 0.23 mm were involved by tumor. The final defect was 13.5 cm x 8.3 cm.  …
Read More
BCC-SRT-superficial-radiation-therapy-orange-county-skin-cancer-basal-cell-carcinoma
Multiple Nasal BCCs
HISTORY 81-year-old man presents with 7-month history of two nasal tip and right nasal ala BCC’s. All three lesions were treated with 2 adjoining SRT fields. The course began 1-8-18 and completed by 1-26-18 after 15 treatments. DISCUSSION This patient represents an excellent candidate for radiation therapy. Electron beam radiation therapy can be used with…
Read More
Thigh-BCC-radiation-oncology-radiotherapy-orange-county-skin-cancer
Large Thigh BCC Treated with Radiation
HISTORY 92-year-old man presents with 15-year history of basal cell carcinoma on left thigh. The 9.3 cm x 8.6 cm superficial plaque was treated with electron beam radiotherapy completing 6000 cGy in 30 fractions on 3-13-2018. DISCUSSION The 6-week course of radiation was tolerated well by this patient. He had minimum oozing from previous biopsy…
Read More
pigmented-bcc-neck-seborrheic-keratosis-orange-county-skin-cancer-pathology
Pigmented BCC of Left Neck
HISTORY 81-year-old man presents with pigmented lesion on left neck. The lesion was excised with 2 mm margins. BCC was found with clear margins. DISCUSSION Pigmented basal cell carcinoma is an uncommon variant of the common skin cancer. Its behavior is that of a non-pigmented basal cell carcinoma. It can be confused with melanoma and…
Read More
Basal-cell-carcinoma-shave-excision-skin-cancer-orange-county-shave-excision-dermablade
Shave excision of Lower Extremity Carcinomas
HISTORY 67-year-old woman presents with 3 BCCs on right lower extremity diagnosed on shave biopsies.  Superficial shave excisions of the carcinomas left close margins within 0.1 mm. Second set of shave excisions found no residual carcinoma.     DISCUSSION Lower leg skin carcinomas are often superficial and can be treated with superficial treatments. This patient’s…
Read More
Lower Leg Wound Treatment At Scars Center
Lower Leg Wound Dehiscence
HISTORY 74-year-old man presents with BCC of left lower leg treated with Mohs excision and closure on 2-27-18. Patient presented 5 days post closure with wound dehiscence. Cutimed wound sponge dressing was used for wound management.  Debridement was performed 3-16-18. Plan is for closure with matrix xenograft.       DISCUSSION Lower leg wound dehiscence…
Read More

STAY UP TO DATE

Receive research updates, inspiring stories, healthy living tips and more.

Something went wrong. Please check your entries and try again.

FOLLOW US

ELEVATING THE STANDARDS OF SKIN CANCER MANAGEMENT.

© 2018 SCARS Management Services. All rights reserved.